Drugs / 3'-deoxy-3'-[F-18] fluorothymidine
3'-deoxy-3'-[F-18] fluorothymidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03318497 | Dec 2017 → Jun 2021 | pancreatic adenocarcinoma | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 3'-deoxy-3'-[F-18] fluorothymidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03318497 ↗ |
| Modality | Diagnostic / imaging agent | “Diagnostic (Interim FLT PET/CT)” NCT03318497 ↗ |
| Route | Intravenous | “Given IV” NCT03318497 ↗ |